[
  {
    "ts": null,
    "headline": "Dupixent gains chronic spontaneous urticaria indication in Europe",
    "summary": "The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decade.",
    "url": "https://finnhub.io/api/news?id=0d545f88f07ac4e94dcedfd4ad9a61951b711ecfbbd350f2f833528f62c61970",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764182275,
      "headline": "Dupixent gains chronic spontaneous urticaria indication in Europe",
      "id": 137614680,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decade.",
      "url": "https://finnhub.io/api/news?id=0d545f88f07ac4e94dcedfd4ad9a61951b711ecfbbd350f2f833528f62c61970"
    }
  },
  {
    "ts": null,
    "headline": "Hedge Funds Pile Into Health Stocks Leading Market in Rotation",
    "summary": "The S&P 500 Health Care Index is up 10% through Tuesday, outperforming the other 10 sectors in the benchmark for US stocks.  Eli Lilly & Co. has surged 29% to become the first health company with a $1 trillion valuation.  Regeneron Pharmaceuticals Inc., Merck & Co. and Biogen Inc. are all up at least 18% since the end of October.",
    "url": "https://finnhub.io/api/news?id=3768daf75b4e70ec346d2eb5b0e4f04e7f887660fac02bb04248c747f2d50a79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764153000,
      "headline": "Hedge Funds Pile Into Health Stocks Leading Market in Rotation",
      "id": 137611229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The S&P 500 Health Care Index is up 10% through Tuesday, outperforming the other 10 sectors in the benchmark for US stocks.  Eli Lilly & Co. has surged 29% to become the first health company with a $1 trillion valuation.  Regeneron Pharmaceuticals Inc., Merck & Co. and Biogen Inc. are all up at least 18% since the end of October.",
      "url": "https://finnhub.io/api/news?id=3768daf75b4e70ec346d2eb5b0e4f04e7f887660fac02bb04248c747f2d50a79"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum",
    "summary": "Regeneron Pharmaceuticals (REGN) shares have shown steady gains over the past month, supported by the company’s consistent revenue and net income growth. Investors are keeping an eye on how Regeneron continues to execute on its existing strengths. See our latest analysis for Regeneron Pharmaceuticals. Regeneron’s impressive 36% one-month share price return has given it real momentum, especially when you consider its steady gains earlier in the year. Over a five-year period, its total...",
    "url": "https://finnhub.io/api/news?id=0d03b90923ad017705f269b3cd8e83c9ba4a1b5a07e7b79b61e37db5ef43bc29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764123129,
      "headline": "Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum",
      "id": 137611529,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals (REGN) shares have shown steady gains over the past month, supported by the company’s consistent revenue and net income growth. Investors are keeping an eye on how Regeneron continues to execute on its existing strengths. See our latest analysis for Regeneron Pharmaceuticals. Regeneron’s impressive 36% one-month share price return has given it real momentum, especially when you consider its steady gains earlier in the year. Over a five-year period, its total...",
      "url": "https://finnhub.io/api/news?id=0d03b90923ad017705f269b3cd8e83c9ba4a1b5a07e7b79b61e37db5ef43bc29"
    }
  }
]